Sage Therapeutics, Inc. Retained Earnings
Sage Therapeutics, Inc. had Retained Earnings of -$3.08 billion as of 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-07-30
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$3.08B.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$3.03B.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$2.97B.
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$2.87B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-06-30 | -$3.08B 10-Q · filed 2025-07-30 |
| 2025-03-31 | -$3.03B 10-Q · filed 2025-04-29 |
| 2024-12-31 | -$2.97B 10-Q · filed 2025-07-30 |
| 2024-09-30 | -$2.87B 10-Q · filed 2024-10-29 |
| 2024-06-30 | -$2.78B 10-Q · filed 2024-07-31 |
| 2024-03-31 | -$2.68B 10-Q · filed 2024-04-25 |
| 2023-12-31 | -$2.57B 10-K · filed 2025-02-11 |
| 2023-09-30 | -$2.54B 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$2.34B 10-Q · filed 2023-08-07 |
| 2023-03-31 | -$2.17B 10-Q · filed 2023-05-02 |
| 2022-12-31 | -$2.03B 10-K · filed 2024-02-14 |
| 2022-09-30 | -$1.88B 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$1.74B 10-Q · filed 2022-08-02 |
| 2022-03-31 | -$1.62B 10-Q · filed 2022-05-03 |
| 2021-12-31 | -$1.50B 10-K · filed 2023-02-16 |
| 2021-09-30 | -$1.37B 10-Q · filed 2021-11-02 |
| 2021-06-30 | -$1.24B 10-Q · filed 2021-08-03 |
| 2021-03-31 | -$1.13B 10-Q · filed 2021-05-04 |
| 2020-12-31 | -$1.04B 10-K · filed 2022-02-24 |
| 2020-09-30 | -$2.01B 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$1.91B 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$1.77B 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$1.64B 10-K · filed 2021-02-24 |
| 2019-09-30 | -$1.47B 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$1.29B 10-Q · filed 2019-08-06 |
| 2019-03-31 | -$1.13B 10-Q · filed 2019-05-02 |
| 2018-12-31 | -$963.33M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$804.94M 10-Q · filed 2018-11-06 |
| 2018-06-30 | -$682.02M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$665.04M 10-Q · filed 2018-05-03 |
| 2017-12-31 | -$590.45M 10-K · filed 2019-02-19 |
| 2017-09-30 | -$521.02M 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$447.31M 10-Q · filed 2017-08-03 |
| 2017-03-31 | -$377.11M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$320.33M 10-K · filed 2018-02-22 |
| 2016-09-30 | -$264.43M 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$226.63M 10-Q · filed 2016-08-09 |
| 2016-03-31 | -$191.88M 10-Q · filed 2016-05-06 |
| 2015-12-31 | -$161.34M 10-K · filed 2017-02-24 |
| 2015-09-30 | -$132.78M 10-Q · filed 2015-11-06 |
| 2015-06-30 | -$108.74M 10-Q · filed 2015-08-12 |
| 2015-03-31 | -$83.72M 10-Q · filed 2015-05-15 |
| 2014-12-31 | -$66.84M 10-K · filed 2016-02-29 |
| 2014-09-30 | -$54.48M 10-Q · filed 2014-11-13 |
| 2014-06-30 | -$44.79M 10-Q · filed 2014-08-14 |
| 2013-12-31 | -$31.68M 10-K · filed 2015-03-06 |